Skip to search formSkip to main contentSkip to account menu

guanoxan

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
: A series of postganglionic neurone blocking agents was administered intraperitoneally in large doses for 2-3 weeks to adult… 
Review
1985
Review
1985
SummaryThe clinical significance of two separate genetic polymorphisms which alter drug metabolism, acetylation and oxidation is… 
1982
1982
The hydroxylation phenotype was determined in a sample of the Swiss population consisting of 222 normal unrelated subjects (131… 
1971
1971
A quantitative g.1.c. method was developed for the routine analysis of orphenadrine in urine and blood plasma, and its mono-N… 
1967
1967
Guanoxan and guanethidine were studied in 52 patients with essential hypertension using a double‐blind crossover technique. No… 
1966
1966
screening test. Negative plates and those with light or mixed growth can be confidently discarded. A heavy pure growth in all… 
1966
1966
Same clinical effects of guanoxan, an adrenergic neuron blocking agent, were studied in ten hypertensive patients. Although the… 
1966
1966
El sulfato de 2-guanidinometil-1:4-benzo-dioxano (guanidino14C) se sintetizó a partir del 2-aminometil-1: 4-benzodioxano y el…